209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?
About this episode
Thomas J. Bollyky discusses the challenges in the US pharmaceutical market and the implications of Trump's tariffs and pricing deal with the UK.
Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).
More episodes of Trade Talks
- 212. America's semiconductor policy and the AI race with China
- 211. How one small American manufacturer is dealing with Trump's tariffs
- 210. What is America's problem with the WTO?
- 208. It's been one year since Trump's "Liberation Day" tariffs
- 207. What happened on Trump's tariff day
- 206. Paul Krugman talks trade, industrial policy, and Trump
Explore listener stats, chart rankings, contacts and more on the Trade Talks podcast page.